Search results for "Guidelines as Topic"

showing 10 items of 372 documents

A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations ; The Lancet Commi…

2016

Elevated blood pressure is the strongest modifiable risk factor for cardiovascular disease worldwide. Despite extensive knowledge about ways to prevent as well as to treat hypertension, the global incidence and prevalence of hypertension and, more importantly, its cardiovascular complications are not reduced—partly because of inadequacies in prevention, diagnosis, and control of the disorder in an ageing world. The aim of the Lancet Commission on hypertension is to identify key actions to improve the management of blood pressure both at the population and the individual level, and to generate a campaign to adopt the suggested actions at national levels to reduce the impact of elevated blood…

medicine.medical_specialtyEvidence-based practicePopulationBlood PressureGuidelines as TopicDiseaseCommission030204 cardiovascular system & hematologyGlobal HealthGlobal Burden of Disease03 medical and health sciences0302 clinical medicineRaised blood pressureRisk FactorsGlobal healthHumansMedicine030212 general & internal medicineeducationIntensive care medicineeducation.field_of_studybusiness.industryGeneral MedicineLifecourseRisk factor (computing)Call to actionSurgeryBlood pressureHypertensionbusiness
researchProduct

Enhanced labelling on alcoholic drinks: reviewing the evidence to guide alcohol policy

2013

Background: Consumer and public health organizations have called for better labelling on alcoholic drinks. However, there is a lack of consensus about the best elements to include. This review summarizes alcohol labelling policy worldwide and examines available evidence to support enhanced labelling. Methods: A literature review was carried out in June-July 2012 on Scopus using the key word 'alcohol' combined with 'allergens', 'labels', 'nutrition information', 'ingredients', 'consumer information' and/or 'warning'. Articles discussing advertising and promotion of alcohol were excluded. A search through Google and the System for Grey Literature in Europe (SIGLE) identified additional source…

medicine.medical_specialtyEvidence-based practicebusiness.industryAlcoholic BeveragesPublic healthPublic Health Environmental and Occupational HealthPoison controlAdvertisingGrey literatureFood LabelingStandard drinkEvidence-Based PracticeLabellingServing sizePractice Guidelines as TopicHumansMedicineHealth educationbusinessNutritive ValueThe European Journal of Public Health
researchProduct

European Society of Gynaecological Oncology guidelines for the peri-operative management of advanced ovarian cancer patients undergoing debulking sur…

2021

The European Society of Gynaecological Oncology (ESGO) developed and established for the first time in 2016, and updated in 2020, quality indicators for advanced ovarian cancer surgery to audit and improve clinical practice in Europe and beyond. As a sequela of the continuous effort to improve oncologic care in patients with ovarian cancer, ESGO issued in 2018 a consensus guidance jointly with the European Society of Medical Oncology addressing in a multidisciplinary fashion 20 selected key questions in the management of ovarian cancer, ranging from molecular pathology to palliation in primary and relapse disease. In order to complement the above achievements and consolidate the promoted sy…

medicine.medical_specialtyEvidence-based practicebusiness.industryObstetrics and GynecologyCancerGuidelines as TopicPerioperativeDiseaseAuditCarcinoma Ovarian Epithelialmedicine.diseaseDebulkingSurgeryScientific evidenceEuropeovarian cancerSettore MED/40 - GINECOLOGIA E OSTETRICIAOncologydebulking surgeryMedicineHumansFemalebusinessOvarian cancerPerioperative Period
researchProduct

Evidence-based Guidelines for the Management of Exocrine Pancreatic Insufficiency After Pancreatic Surgery

2016

Objective: To provide evidence-based recommendations for the management of exocrine pancreatic insufficiency (EPI) after pancreatic surgery. Background: EPI is a common complication after pancreatic surgery but there is certain confusion about its frequency, optimal methods of diagnosis, and when and how to treat these patients. Methods: Eighteen multidisciplinary reviewers performed a systematic review on 10 predefined questions following the GRADE methodology. Six external expert referees reviewed the retrieved information. Members from Spanish Association of Pancreatology were invited to suggest modifications and voted for the quantification of agreement. Results: These guidelines analyz…

medicine.medical_specialtyEvidence-based practicediagnosisMEDLINEGuidelines030230 surgeryGastroenterologyPancreatic surgerysurgery03 medical and health sciencesPostoperative Complications0302 clinical medicineInternal medicineparasitic diseasesmedicineHumansGuidelines Management Exocrine Pancreatic Insufficiency Pancreatic SurgerypancreasguidelinesExocrine pancreatic insufficiencyPancreatic SurgeryConfusionpancreatic exocrine insufficiencyEvidence-Based Medicinetreatmentbusiness.industryPancreatic DiseasesEvidence-based medicinemedicine.diseaseManagementSurgerySpainpancreaticPractice Guidelines as TopicExocrine Pancreatic Insufficiency030211 gastroenterology & hepatologySurgerymedicine.symptomComplicationOptimal methodsbusinessAnnals of Surgery
researchProduct

Letter regarding article titled ‘Microembolism during foam sclerotherapy of varicose veins’ in the New England Journal of Medicine

2008

medicine.medical_specialtyForamen ovale patentHeart Diseasesbusiness.industrymedicine.medical_treatmentSclerosing SolutionsForamen Ovale PatentGeneral MedicineSclerosing SolutionsSurgeryVaricose VeinsNew englandPractice Guidelines as TopicSclerotherapyVaricose veinsmedicineSclerotherapyEmbolism AirHumansmedicine.symptomCardiology and Cardiovascular MedicinebusinessUltrasonographyPhlebology: The Journal of Venous Disease
researchProduct

Utilizing nutritional genomics to tailor diets for the prevention of cardiovascular disease: a guide for upcoming studies and implementations.

2017

Introduction: Personalized diets based on an individual’s genome to optimize the success of dietary intervention and reduce genetic cardiovascular disease (CVD) risk, is one of the challenges most frequently discussed in the scientific community. Areas covered: The authors gathered literature-based evidence on nutritional genomics and CVD phenotypes, our own results and research experience to provide a critical overview of the current situation of using nutritional genomics to tailor diets for CVD prevention and to propose guidelines for future studies and implementations. Expert commentary: Hundreds of studies on gene-diet interactions determining CVD intermediate (plasma lipids, hypertens…

medicine.medical_specialtyFuture studiesNutritional genomicsMediterranean dietDisease030204 cardiovascular system & hematologyBioinformaticsNutrigeneticsPathology and Forensic MedicineScientific evidence03 medical and health sciences0302 clinical medicineNutrigenomicsMediterranean dietPlasma lipidsGeneticsMedicineHumans030212 general & internal medicineDietary patternsIntensive care medicineMolecular BiologyNutrigeneticsbusiness.industryPrecision nutritionNutrientsCardiovascular diseaseLipidsDietNutrigenomicsCardiovascular DiseasesPersonalized dietsPractice Guidelines as TopicMolecular MedicineGenetic risk scoresbusinessDiet TherapyExpert review of molecular diagnostics
researchProduct

Treatment challenges in and outside a network setting: Soft tissue sarcomas

2019

Patients with soft tissue sarcoma (STS) experienced better outcomes when treated according to existing clinical practice guidelines either at reference institution or dedicated treatment networks. Despite increasing evidence supporting referral to sarcoma specialised units, up to half of patients are not managed according to guidelines, particularly those in the early stage of their disease requiring surgery. Also, criteria to certify expertise of institutions, such as the treatment volume, are debated and health authorities have only recently started identification of these centres and creation of treatment networks in Europe as well as in several countries. This process have important imp…

medicine.medical_specialtyGuidelines; Network; Referral centre; Sarcoma; Treatment; Surgery; OncologyReferralReferral centrePopulationMEDLINESocio-culturaleNetworkDiseaseCancer Care FacilitiesGuidelinesGuideline03 medical and health sciencesRare Diseases0302 clinical medicineRare DiseaseHealth careGuidelines; Network; Referral centre; Sarcoma; TreatmentmedicineHumans030212 general & internal medicineRegistrieseducationReferral and Consultationeducation.field_of_studybusiness.industryCancer Care FacilitieSoft tissue sarcomaCancer Care FacilitiesSarcomaGeneral Medicinemedicine.diseaseSurgeryTreatmentEuropeClinical researchOncology030220 oncology & carcinogenesisPractice Guidelines as TopicSurgeryMedical emergencybusinessDelivery of Health CareHuman
researchProduct

Hereditary gastrointestinal cancers: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

2019

Knowledge of genetic susceptibility to gastrointestinal cancers is constantly evolving with identification of new genes. Similarly, a better understanding of the genotype/phenotype relationship in patients with Lynch syndrome (LS) or familial adenomatous polyposis (FAP) is leading to more individualised surveillance recommendations. In addition, molecular profiling of patients with cancer has been shown to guide targeted therapies, such as immunotherapy. Specialists involved in the care of patients with gastrointestinal cancer should be familiar with the main hereditary cancer syndromes and refer patients to specialised cancer genetic units for adequate genetic counselling and to address sp…

medicine.medical_specialtyHealth Planning Guidelinesbusiness.industryMEDLINEHematologyPrognosisCombined Modality TherapyClinical PracticeText miningOncologyDiagnosis treatmentPractice Guidelines as TopicmedicineMolecular diagnostic techniquesHumansGenetic Predisposition to DiseasebusinessIntensive care medicineSocieties MedicalFollow-Up StudiesGastrointestinal Neoplasms
researchProduct

The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness.

2019

The poor physical health of people with mental illness is a multifaceted, transdiagnostic, and global problem. People with mental illness have an increased risk of physical disease, as well as reduced access to adequate health care. As a result, physical health disparities are observed across the entire spectrum of mental illnesses in low-income, middle-income, and high-income countries. The high rate of physical comorbidity, which often has poor clinical management, drastically reduces life expectancy for people with mental illness, and also increases the personal, social, and economic burden of mental illness across the lifespan. This Commission summarises advances in understanding on the…

medicine.medical_specialtyHealth StatusDiseaseComorbidity03 medical and health sciences0302 clinical medicineHealth caremedicineHumans030212 general & internal medicinePsychiatryBiological PsychiatryHealth policybusiness.industryPhysical health mental illnessMental DisordersMental illnessmedicine.diseaseComorbidityMental health030227 psychiatryPsychiatry and Mental healthHealth promotionPractice Guidelines as TopicLife expectancybusinessPsychologyThe lancet. Psychiatry
researchProduct

Recommendations of the Geriatric Cardiology Section of the Spanish Society of Cardiology for the Assessment of Frailty in Elderly Patients With Heart…

2018

Frailty is an age-associated clinical syndrome characterized by a decrease in physiological reserve in situations of stress, constituting a state of vulnerability that involves a higher risk of adverse events. Its prevalence in Spain is high, especially in elderly individuals with comorbidity and chronic diseases. In cardiovascular disease, frailty is associated worse clinical outcomes and higher morbidity and mortality in all scenarios, in both acute and chronic settings, and could consequently influence diagnosis and treatment. However, frailty is often not addressed or included when planning the management of elderly patients with heart disease. In this article, we review the available s…

medicine.medical_specialtyHeart DiseasesHeart diseaseGerontologíaFrail ElderlyEnfermedad cardiovascularCardiologyVulnerabilityGuidelines as TopicContext (language use)Cardiología geriátricaDisease030204 cardiovascular system & hematologyScientific evidence03 medical and health sciencesGeriatric cardiology0302 clinical medicinemedicineValoración geriátricaHumansAdverse effectIntensive care medicineGeriatric AssessmentAged 80 and overFrailtybusiness.industryGeneral Medicinemedicine.diseaseComorbidityGeriatricsSpainMorbiditybusinessRevista Española de Cardiología (English Edition)
researchProduct